BSE Live
Sep 05, 16:01Prev. Close
3325.75
Open Price
3318.50
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Sep 05, 15:51Prev. Close
3319.40
Open Price
3309.00
Bid Price (Qty.)
3249.60 (7)
Offer Price (Qty.)
0.00 (0)
Balance Sheet of Dr Lal PathLabs (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 83.59 | 83.48 | 83.37 | 83.35 | 83.35 | |
Total Share Capital | 83.59 | 83.48 | 83.37 | 83.35 | 83.35 | |
Reserves and Surplus | 2,050.64 | 1,765.18 | 1,548.48 | 1,335.68 | 1,093.94 | |
Total Reserves and Surplus | 2,050.64 | 1,765.18 | 1,548.48 | 1,335.68 | 1,093.94 | |
Total Shareholders Funds | 2,134.23 | 1,899.66 | 1,689.86 | 1,476.47 | 1,217.09 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 0.00 | 0.00 | 83.33 | 166.67 | 0.00 | |
Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Long Term Liabilities | 98.28 | 91.34 | 114.81 | 120.96 | 103.74 | |
Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Non-Current Liabilities | 98.28 | 91.34 | 198.15 | 287.63 | 103.74 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 0.00 | 83.33 | 153.34 | 178.76 | 0.00 | |
Trade Payables | 193.05 | 167.31 | 140.16 | 123.35 | 135.57 | |
Other Current Liabilities | 161.77 | 143.14 | 115.43 | 127.34 | 100.80 | |
Short Term Provisions | 33.62 | 30.66 | 23.24 | 20.38 | 15.88 | |
Total Current Liabilities | 388.44 | 424.44 | 432.16 | 449.82 | 252.25 | |
Total Capital And Liabilities | 2,620.95 | 2,415.44 | 2,320.17 | 2,213.92 | 1,573.08 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 320.69 | 293.98 | 345.17 | 351.42 | 283.14 | |
Intangible Assets | 697.14 | 14.99 | 16.31 | 18.71 | 16.93 | |
Capital Work-In-Progress | 3.48 | 3.95 | 2.97 | 14.45 | 5.51 | |
Other Assets | 33.36 | 33.71 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 1,054.66 | 348.32 | 366.41 | 384.58 | 309.06 | |
Non-Current Investments | 113.94 | 1,072.80 | 1,072.03 | 1,069.04 | 120.40 | |
Deferred Tax Assets [Net] | 84.53 | 38.63 | 32.55 | 30.01 | 26.92 | |
Long Term Loans And Advances | 0.00 | 0.03 | 0.06 | 0.11 | 0.07 | |
Other Non-Current Assets | 90.53 | 35.11 | 38.95 | 33.80 | 27.33 | |
Total Non-Current Assets | 1,343.67 | 1,494.89 | 1,510.00 | 1,517.53 | 483.78 | |
CURRENT ASSETS | ||||||
Current Investments | 301.70 | 70.03 | 141.38 | 0.00 | 50.21 | |
Inventories | 32.27 | 27.52 | 23.34 | 39.72 | 38.94 | |
Trade Receivables | 105.40 | 77.79 | 63.32 | 66.65 | 63.54 | |
Cash And Cash Equivalents | 767.54 | 683.12 | 534.22 | 540.61 | 888.63 | |
Short Term Loans And Advances | 1.02 | 1.16 | 1.24 | 0.94 | 0.79 | |
OtherCurrentAssets | 69.37 | 60.94 | 46.68 | 48.48 | 47.19 | |
Total Current Assets | 1,277.28 | 920.55 | 810.17 | 696.39 | 1,089.30 | |
Total Assets | 2,620.95 | 2,415.44 | 2,320.17 | 2,213.92 | 1,573.08 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 21.33 | 20.23 | 18.01 | 25.99 | 19.18 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 3.80 | 5.69 | 10.14 | 9.83 | 10.53 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | -- | -- | -- | -- | -- | |
Other Earnings | 27.83 | 25.89 | 22.02 | 18.79 | 14.31 | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | 50.32 | 50.32 | 50.32 | 50.32 | 50.32 | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Non-Current Investments Unquoted Book Value | 113.94 | 1,072.80 | 1,072.03 | 1,069.04 | 120.40 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | -- | -- | -- | -- | 50.21 |
01.08.2025
Dr Lal PathLab Consolidated June 2025 Net Sales at Rs 669.80 crore, up 11.28% Y-o-Y
31.07.2025
Dr Lal PathLab Standalone June 2025 Net Sales at Rs 640.70 crore, up 19.87% Y-o-Y
22.07.2025
23.06.2025
Dr Lal PathLabs, Metropolis, others fall up to 2% as Amazon launches home diagnostics services
01.08.2025
Dr Lal PathLab Consolidated June 2025 Net Sales at Rs 669.80 crore, up 11.28% Y-o-Y
31.07.2025
Dr Lal PathLab Standalone June 2025 Net Sales at Rs 640.70 crore, up 19.87% Y-o-Y
25.04.2025
Dr Lal PathLab Standalone March 2025 Net Sales at Rs 577.20 crore, up 20.5% Y-o-Y
25.04.2025
Dr Lal PathLab Consolidated March 2025 Net Sales at Rs 602.60 crore, up 10.49% Y-o-Y
06.10.2021
Dr. Lal PathLabs Q2 PAT seen up 28.4% YoY to Rs 112 cr: Prabhudas Lilladher
18.01.2021
Dr. Lal PathLabs Q3 PAT seen up 27.4% YoY to Rs. 54.1 cr: Prabhudas Lilladher
11.10.2019
Dr Lal Pathlabs Q2 PAT seen up 48.8% YoY to Rs. 84.8 cr: Kotak
15.07.2019
Dr Lal Pathlabs Q1 PAT seen up 17.6% YoY to Rs. 58.1 cr: Kotak